Assessment of functioning and disability in pain syndromes

Behavioral and Psychopharmacologic Pain Management

Volumn , Issue , 2010, Pages 67-81

  Parenteau, Stacy C ^a   Haythornthwaite, Jennifer A ^b  

^a SCOTT AND WHITE MEMORIAL HOSPITAL   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84889091375     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1017/CBO9780511781445.005     Document Type: Chapter

References (112)

1. Serlin RC, Mendoza TR, Nakamura Y, et al. When is cancer pain mild, moderate or severe? Grading pain severity by its interference with function. Pain 1995; 61:277-84.
2. Rudy TE, Lieber SJ, Boston JR, et al. Psychosocial predictors of physical performance in disabled individuals with chronic pain. Clin JPain 2003; 19:18-30.
3. Tyler EJ, Jensen MP, Engel JM, et al. The reliability and validity of pain interference measures in persons with cerebral palsy. Arch Phys Med Rehabil 2002; 83: 236-9.
4. Deshields TL, Tait RC, Gfeller JD, et al. Relationship between social desirability and self-report in chronic pain patients. Clin J Pain 1995; 11: 189-93.
5. de Bock GH, Hermans J, van Marwijk HW, et al.Health-related quality of life assessments in osteoarthritis during NSAID treatment. Pham World Sci 1996; 18:130-6.
6. Tait RC, Pollard CA, Margolis RB, et al. The Pain Disability Index: Psychometric and validity data. Arch Phys Med Rehabil 1987; 68: 438-41.
7. Daut RL, Cleeland CS, Flanery RC. Development of the Wisconsin Brief Pain Questionnaire to assess pain in cancer and other diseases. Pain 1983; 17: 197-210.
8. Kerns R, Turk D, Rudy T. The West Haven-Yale Multidimensional Pain Inventory (WHYMPI). Pain 1985; 23:345-56.
9. Bergner M, Bobbitt RA, Carter WB, et al. The sickness impact profile: Development and final revision of a health status measure. Med Care 1981; 19: 787-805.
10. Lousberg R, Van Breukelen GJ, Groenman NH, et al.Psychometric properties of the Multidimensional Pain Inventory, Dutch language version (MPI-DLV). Behav Res Ther 1999; 37: 167-82.
11. Schwarz N. Self-reports: How the questions shape the answers. Am Psychol 2003; 54: 93-105.
12. Anderson KO, Syrjala KL, Cleeland CS. Howto assess cancer pain. In Handbook of Pain Assessment. 2nd edn, eds. DC Turk DC and R Melzack. (New York: Guilford Press, 2001), pp. 579-600.
13. Cleeland CS, Ryan KM. Pain assessment: Global use of the Brief Pain Inventory. Ann Acad Med Singapore 1994; 23:129-38.
14. Cleeland CS, Nakamura Y, Mendoza TR, et al. Dimensions of the impact of cancer pain in a four country sample: new information from multidimensional scaling. Pain 1996; 67: 267-73.
15. Portenoy RK, Miransky J, Thaler HT, et al. Pain in ambulatory patients with lung or colon cancer. Prevalence, characteristics, and effect. Cancer 1992; 70: 1616-24.
16. Radbruch L, Loick G, Kiencke P, et al. Validation of the German version of the Brief Pain Inventory. J Pain Symptom Manage 1999; 18:180-7.
17. Owen JE, Klapow JC, Casebeer L. Evaluatingthe relationship between pain presentation and health-related quality of life in outpatients with metastatic or recurrent neoplastic disease. Qual Life Res 2000; 9: 855-63.
18. Smith MY, Egert J, Winkel G, et al. The impact of PTSD on pain experience in persons with HIV/AIDS. Pain 2002; 98: 9-17.
19. Hardy JR, Rees EA, Gwilliam B, et al. A phase II study to establish the efficacy and toxicity of so dium valproate in patients with cancer-related neuropathic pain. J Pain Symptom Manage 2001; 21:204-9.
20. Wallace M, Rauck RL, Moulin D, et al. Conversion from standard opioid therapy to once-daily oral extended-release hydromorphone in patients with chronic cancer pain. JInt Med Res 2008; 36: 343-52.
21. White WT, Patel N, Drass M, et al. Lidocaine patch 5% with systemic analgesics such as gabapentin: A rational polypharmacy approach for the treatment of chronic pain. Pain Med 2003; 4: 321-30.
22. Du Pen SL, Du Pen AR, Polissar N, et al. Implementing guidelines for cancer pain management: Results of a randomized controlled clinical trial. J Clin Oncol 1999; 17: 361-70.
23. Schiffmann R, Kopp JB, Austin HA, III, et al. Enzyme replacement therapy in Fabry disease: A randomized controlled trial. JAMA 2001; 285:2743-9.
24. Armstrong DG, Chappell AS, Le TK, et al. Duloxetine for the management of diabetic peripheral neuropathic pain: Evaluation of functional outcomes. Pain Med 2007;8:410-8.
25. Passard A, Attal N, Benadhira R, et al. Effects of unilateral repetitive transcranial magnetic stimulation of the motor cortex on chronic widespread pain in fibromyalgia. Brain 2007; 130: 2661-70.
26. Cowan DT, Wilson-Barnett DJ, Griffiths P, et al. A randomized, double-blind, placebo-controlled, cross-over pilot study to assess the effects of long-term opioid drug consumption and subsequent abstinence in chronic noncancer pain patients receiving controlled-release morphine. Pain Med 2005; 6:113-21.
27. Evans S, Fishman B, Spielman L, et al. Randomized trial of cognitive behavior therapy versus supportive psychotherapy for HIV-related peripheral neuropathic pain. Psychosomatics 2003; 44:44-50.
28. Ersek M, Turner JA, Cain KC, et al. Results of a randomized controlled trial to examine the efficacy of a chronic pain self-management group for older adults [ISRCTN11899548]. Pain 2008; 138: 29-40.
29. Rutledge DN, Jones CJ. Effects of topical essential oil on exercise volume after a 12-week exercise program for women with fibromyalgia: A pilot study. J Altern Complement Med 2007; 13: 1099-106.
30. Chibnall JT, Tait RC. The Pain Disability Index: Factor structure and normative data. Arch Phys Med Rehabil 1994; 75:1082-6.
31. Arkinstall W, Sandler W, Goughnour B, et al. Efficacy of controlled-release codeine in chronic non-malignant pain: A randomized, placebo-controlled clinical trial. Pain 1995; 62: 169-78.
32. Jerome A, Gross RT. Pain disability index: Construct and discriminant validity. Arch Phys Med Rehabil 1991; 72: 920-2.
33. Gronblad MMD, Jarvinen EMS, Hurri HMD, et al.Relationship of the Pain Disability Index (PDI) and the Oswestry Disability Questionnaire (ODQ) with three dynamic physical tests in a group of patients with chronic low-back and leg pain. Clin J Pain 1994; 10: 197-203.
34. Harke H, Gretenkort P, Ladleif HU, et al. Spinal cord stimulation in postherpetic neuralgia and in acute herpes zoster pain. Anesth Analg2002; 94: 694-700.
35. Eisenberg E, Lurie Y, Braker C, et al. Lamotrigine reduces painful diabetic neuropathy: A randomized, controlled study. Neurology 2001; 57: 505-9.
36. Harden RN, Brenman E, Saltz S, et al. Topiramate in the management of spinal cord injury pain: A double-blind, randomized, placeb-controlled pilot study. In Spinal Cord Injury: Assessment, mechanisms, management. 23rd edn, eds. RP Yezierski and KJ Burchiel. (Seattle: IASP Press, 2002), pp. 393-407.
37. Gronblad M, Hupli M, Wennerstrand P, et al. Intercorrelation and test-retest reliability of the Pain Disability Index (PDI) and the Oswestry Disability Questionnaire (ODQ) and their correlation with pain intensity in low back pain patients. Clin J Pain 1993; 9: 189-95.
38. Gronblad M, Jarvinen E, Airaksinen O, et al. Relationship of subjective disability with pain intensity, pain duration, pain location, and work-related factors in nonoperated patients with chronic low back pain. Clin J Pain 1996; 12: 194-200.
39. Rochmon DL, Ray SA, Kullch RJ, et al. Validity and utility of the Canadian occupational performance measure as an outcome measure in a craniofacial pain center. OTJR: Occupation, Participation and Health 2008; 28:4-11.
40. Brown CS, Ling FW, Wan JY, et al. Efficacy of static magnetic field therapy in chronic pelvic pain: A double-blind pilot study. Am J Obstet Gynecol 2002; 187: 1581-7.
41. Nurmikko TJ, Serpell MG, Hoggart B, et al. Sativex successfully treats neuropathic pain characterised by allodynia: A randomised, double-blind, placebocontrolled clinical trial. Pain 2007; 133:210-20.
42. Vranken JH, Dijkgraaf MGW, Kruis MR, et al. Iontophoretic administration of S(+)-ketamine in patients with intractable central pain: A placebocontrolled trial. Pain 2005; 118: 224-31.
43. Lurie Y, Brecker C, Daoud D, et al. Lamotrigine in the treatment of painful diabetic neuropathy: A randomized, placebo-controlled study. In Proceedings of the 9th World Congress on Pain. 16th edn, eds M. Devor, MC Rowbotham and Z. Wiesenfeld-Hallin. (Seattle: IASP Press, 2000), pp. 857-61.
44. Vranken JH, Dijkgraaf MGW, Kruis MR, et al. Pregabalin in patients with central neuropathic pain: A randomized, double-blind, placebo-controlled trial of a flexible-dose regimen. Pain 2008; 136: 150-7.
45. Hawk C, Long CR, Rowell RM, et al. A randomized trial investigating a chiropractic manual placebo: A novel design using standardized forces in the delivery of active and control treatments. J Altern Complement Med2005; 11:109-17.
46. Bergner M, Bobbitt RA, Kressel S, et al. The sickness impact profile: Conceptual formulation and methodology for the development of a health status measure. Int J Health Serv 1976; 6: 393-415.
47. Jensen MP, Turner JA, Romano JM, et al. Relationship of pain specific beliefs to chronic pain adjustment. Pain 1994; 57: 301-9.
48. Follick MJ, Smith TJ, Ahern DK. The sickness impact profile: A global measure of disability in chronic low bakc pain. Pain 1985; 21: 67-76.
49. Sullivan M, Ahlmen M, Bjelle A. Health status assessment in rheumatoid arthritis. I. Further work on the validity of the sickness impact profile. J Rheumatol 1990; 17: 439-47.
50. Romano JM, Turner JA, Jensen MP, et al. Chronic pain patient-spouse behavioral interactions predict patient disability. Pain 1995; 63: 353-60.
51. Epping-Jordan JE, Wahlgren DR, Williams RA, et al. Transition to chronic pain in men with low back pain: Predictive relationships among pain intensity, disability, and depressive symptoms. Health Psychol 1998;17:421-7.
52. Jensen MP, Turner MA, Romano JM. Correlates of improvement in multidisciplinary treatment of chronic pain. J ConsultClin Psychol 1994; 62:172-9.
53. Burchiel KJ, Anderson VC, Brown FD, et al.Prospective, multicenter study of spinal cord stimulation for relief of chronic back and extremity pain. Spine 1996; 21:2786-94.
54. Risch SV, Norvell NK, Pollock ML, et al. Lumbar strengthening in chronic low back pain patients. Physiologic and psychological benefits. Spine 1993; 18:232-8.
55. Spincemaille GH, Klomp HM, Steyerberg EW, et al. Pain and quality of life in patients with critical limb ischaemia: Results of a randomized controlled multicentre study on the effect of spinal cord stimulation. EurJPain 2000; 4:173-84.
56. Tak E, Staats P, Van HA, et al. The effects of an exercise program for older adults with osteoarthritis of the hip. J Rheumatol 2005; 32: 1106-13.
57. Moulin DE, Iezzi A, Amireh R, et al. Randomized trial of oral morphine for chronic non-cancer pain. Lancet 1996; 347:143-7.
58. Carette S, Bell MJ, Reynolds WJ, et al. Comparison of amitriptyline, cyclobenzaprine, and placebo in the treatment of fibromyalgia. A randomized, double-blind clinical trial [see comments]. Arthritis Rheum 1994; 37: 32 -40.
59. Atkinson JH, Slater MA, Williams RA, et al. A placebo-controlled randomized clinical trial of nortriptyline for chronic low back pain. Pain 1998; 76: 287-96.
60. van Santen M, Bolwijn P, Verstappen F, et al. A randomized clinical trial comparing fitness and biofeedback training versus basic treatment in patients with fibromyalgia. J Rheumatol 2002; 29: 575-81.
61. Rudy TE. Multiaxial assessment of pain Multidimensional pain inventory Computer program user’s manual Version 2.1. (Pittsburgh: University of Pittsburgh School of Medicine, 1989), 1-72.
62. Riley JL, III, Zawacki TM, Robinson ME, et al.Empirical test of the factor structure of the West Haven-Yale Multidimensional Pain Inventory. Clin J Pain 1999; 15: 24-30.
63. Strong J, Westbury K, Smith G, et al. Treatment outcome in individuals with chronic pain: Is the Pain Stages of Change Questionnaire (PSOCQ) a useful tool? Pain 2002; 97: 65-73.
64. Deisinger JA, Cassisi JE, Lofland KR, et al. An examination of the psychometric structure of the Multidimensional Pain Inventory. J Clin Psychol 2001; 57: 765-83.
65. Bergstrom G, Jensen IB, Bodin L, et al. Reliability and factor structure of the Multidimensional Pain Inventory - Swedish Language Version (MPI-S). Pain 1998; 75:101-10.
66. Lousberg R, Schmidt AJ, Groenman NH, et al.Validating the MPI-DLV using experience sampling data. JBehavMed 1997; 20:195-206.
67. Olsson I, Bunketorp O, Carlsson SG, et al. Prediction of outcome in whiplash-associated disorders using West Haven-Yale Multidimensional Pain Inventory. Clin J Pain 2002; 18:238-44.
68. Hooten WM, Townsend CO, Sletten CD, et al.Treatment outcomes after multidisciplinary pain rehabilitation with analgesic medication withdrawal for patients with fibromyalgia. Pain Med 2007; 8: 8-16.
69. Hooten WM, Townsend CO, Decker PA. Gender differences among patients with fibromyalgia undergoing multidisciplinary pain rehabilitation. Pain Med 2007; 8: 624-32.
70. Turk DC, Okifuji A, Sinclair JD, et al. Interdisciplinary treatment for fibromyalgia syndrome: Clinical and statistical significance. Arthritis Care Res 1998; 11: 186-95.
71. Nielson WR, Walker C, McCain GA. Cognitive behavioral treatment of fibromyalgia syndrome: Preliminary findings. J Rheumatol 1992; 19: 98-103.
72. Turk DC, Rudy TE, Kubinski JA, et al. Dysfunctional patients with temporomandibular disorders: Evaluating the efficacy of a tailored treatment protocol. J Consult Clin Psychol 1996; 64: 139-46.
73. Spence SH, Sharpe L, Newton-John T, et al. Effect of EMG biofeedback compared to applied relaxation training with chronic, upper extremity cumulative trauma disorders. Pain 1995; 63:199-206.
74. Flor H, Birbaumer N. Comparison of the efficacy of electromyographic biofeedback, cognitive-behavioral therapy, and conservative medical interventions in the treatment of chronic musculoskeletal pain. J Consult Clin Psychol 1993; 61: 653-8.
75. Kjellby-Wendt G, Styf J, Carlsson SG. Early active rehabilitation after surgery for lumbar disc herniation: A prospective, randomized study of psychometric assessment in 50 patients. Acta Orthop Scand 2001;72:518-24.
76. Raja SN, Haythornthwaite JA, Pappagallo M, et al. Opioids versus antidepressants in postherpetic neuralgia: A randomized, placebo-controlled trial. Neurology 2002; 59: 1015-21.
77. Wallace MS, Magnuson S, Ridgeway B. Efficacy of oral mexiletine for neuropathic pain with allodynia: A double-blind, placebo-controlled, crossover study. Reg Anesth Pain Med 2000; 25:459-67.
78. Martin DP, Sleyren CD, Williams BA, et al. Improvement in fibromyalgia symptoms with acupuncture: Results of a randomized controlled trial. Mayo Clin Proc 2006; 81: 749-57.
79. Harding VR, de CW, Richardson PH, et al. The development of a battery of measures for assessing physical functioning of chronic pain patients. Pain 1994;58:367-75.
80. Brooks D, Davis AM, Naglie G. Validity of 3 physical performance measures in inpatient geriatric rehabilitation. Arch Phys Med Rehabil 2006; 87:105-10.
81. Maly MR, Costigan PA, Olney SJ. Determinants of self-report outcome measures in people with knee osteoarthritis. Arch Phys Med Rehabil 2006; 87: 96-104.
82. Walsh DA, Kelly SJ, Johnson PS, et al. Performance problems of patients with chronic low-back pain and the measurement of patient-centered outcome. Spine 2004;29:87-93.
83. Williams AC, Richardson PH, Nicholas MK, et al. Inpatient vs. outpatient pain management: Results of a randomised controlled trial. Pain 1996; 66:13-22.
84. An B, Dai K, Zhu Z, et al. Baduanjin alleviates the symptoms of knee osteoarthritis. JAltern Complement Med 2008; 14: 167-74.
85. Pfingsten M, Leibing E, Harter W, et al. Fear-avoidance behavior and anticipation of pain in patients with chronic low back pain: A randomized controlled study. Pain Med 2001; 2:259-66.
86. Weiner DK, Rudy TE, Glick RM, et al. Efficacy of percutaneous electrical nerve stimulation for the treatment of chronic low back pain in older adults. J Am Geriatr Soc 2003; 51: 599-608.
87. Frestedt J, Walsh M, Kuskowski M, et al. A natural mineral supplement provides relief from knee osteoarthritis symptoms: A randomized controlled pilot trial. Nutr J 2008; 7: 9.
88. Ng L, Chaudhary N, Sell P The efficacy of corticosteroids in periradicular infiltration for chronic radicular pain: A randomized, double-blind, controlled trial. Spine 2005; 30: 857-62.
89. Smeets RJEM, Vlaeyen JWS, Hidding A, et al. Chronic low back pain: Physical training, graded activity with problem solving training, or both. The one-year posttreatment results of a randomized controlled trial. Pain 2008;134:263-76.
90. Haythornthwaite JA, Hegel MT, Kerns RD. Development of a sleep diary for chronic pain patients. J Pain Symptom Manage 1991; 6: 65-72.
91. Menefee LA, Frank ED, Doghramji K, et al. Self-reported sleep quality and quality of life for individuals with chronic pain conditions. Clin J Pain 2000; 16:290-7.
92. Smith MT, Perlis ML, Smith MS, et al. Sleep quality and presleep arousal in chronic pain. J Behav Med 2000; 23: 1-13.
93. Rowbotham M, Harden N, Stacey B, et al. Gabapentin or the treatment of postherpetic neuralgia: A randomized controlled trial. JAMA 1998; 80: 1837-42.
94. Ahn SH, Park HW, Lee BS, et al. Gabapentin effect on neuropathic pain compared among patients with spinal cord injury and different durations of symptoms. Spine 2003; 28: 341-6.
95. Watson CP, Vernich L, Chipman M, et al. Nortriptyline versus amitriptyline in postherpetic neuralgia: A randomized trial. Neurology 1998; 51: 1166-71.
96. Bone M, Critchley P, Buggy DJ. Gabapentin in postamputation phantom limb pain: A randomized, double-blind, placebo-controlled, cross-over study. RegAnesth Pain Med 2002; 27: 481-6.
97. Finnerup NB, Sindrup SH, Bach FW, et al.Lamotrigine in spinal cord injury pain: A randomized controlled trial. Pain 2002; 96: 375-83.
98. Tolle T, Freynhagen R, Versavel M, et al. Pregabalin for relief of neuropathic pain associated with diabetic neuropathy: A randomized, double-blind study. Eur J Pain 2008;12:203-13.
99. Bone M, Critchley P, Buggy DJ. Gabapentin in postamputation phantom limb pain: A randomized, double-blind, placebo-controlled, cross-over study. Reg Anesth Pain Med 2002; 27: 481-6.
100. Fishbain DA, Hall J, Meyers AL, et al. Does pain mediate the pain interference with sleep problem in chronic pain? Findings from studies for management of diabetic peripheral neuropathic pain with duloxetine. J Pain Symptom Manage 2008; 36: 639-47.
101. Kosinski M, Janagap CC, Gajria K, Schein J Psychometric testing and validation of the Chronic Pain Sleep Inventory. Clin Ther2007; 29 (Suppl 1): 2562-77.
102. Florete OG, Xiang J, Vorsanger GJ. Effects of extended-release tramadol on pain-related sleep parameters in patients with osteoarthritis. Expert Opin Pharmacother 2008; 9: 1817-27.
103. Kivitz A, Ma C, Ahdieh H, et al. A 2-week, multicenter, randomized, double-blind, placebocontrolled, dose-ranging, phase III trial comparing the efficacy of oxymorphone extended release and placebo in adults with pain associated with osteoarthritis of the hip or knee. Clin Ther 2006; 28: 352-64.
104. Harati Y, Gooch C, Swenson M, et al. Double-blind randomized trial of tramadol for the treatment of the pain of diabetic neuropathy. Neurology 1998; 50: 1842-6.
105. Arnold LM, Russell IJ, Diri EW, et al. A 14-week, randomized, double-blinded, placebo-controlled monotherapy trial of pregabalin in patients with fibromyalgia. JPain 2008; 9: 792-805.
106. Currie SR, Wilson KG, Pontefract AJ, et al. Cognitive-behavioral treatment of insomnia secondary to chronic pain. J Consult Clin Psychol 2000; 68: 407-16.
107. Tugwell P, Boers M, Brooks P, et al. OMERACT: An international initiative to improve outcome measurement in rheumatology. Trials 2007; 8: 38.
108. Dworkin RH, Turk DC, Wyrwich KW, et al.Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT Recommendations. JPain 2008; 9: 105-21.
109. Rose M, Bjorner JB, Becker J, et al. Evaluation of a preliminary physical function item bank supported the expected advantages of the Patient-Reported Outcomes Measurement Information System (PROMIS). JClin Epidemiol 2008; 61:17-33.
110. Smith MT, Haythornthwaite JA. How do sleep disturbance and chronic pain inter-relate? Insights from the longitudinal and cognitive-behavioral clinical trials literature. Sleep Med Rev 2004; 8: 119-32.
111. Buysse DJ, Reynolds CF, III, Monk TH, et al. The Pittsburgh Sleep Quality Index: A new instrument for psychiatric practice and research. Psychiatry Res 1989; 28: 193-213.
112. Edinger JD, Wohlgemuth WK, Krystal AD, et al.Behavioral insomnia therapy for fibromyalgia patients: A randomized clinical trial. Arch Intern Med 2005; 165:2527-35.